ReviewCureus2025

Safety and Efficacy of Anti-B-cell Maturation Antigen (Anti-BCMA) Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials.

Asad Ali Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.